(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LOGIKINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LOGIKINE

ST13

US500000097021075

Class

5, 42

Filing

97021075

Registration

7470614

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

08/13/2024

Trademark type

Word

Nice classes

5, 42

Filing date

09/10/2021

Registration date

08/13/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/13/2024

Last transaction

08/13/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

Jiangsu, CN

Examiner

MMEJE, OBIEZE GINIKANWA

Law office

N40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Suzhou Fuse Biosciences Limited

Representatives

Mark A. Jansen Fenwick & West LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Therapeutic agents and preparations consisting primarily of biochemicalsimmunoglobulinantigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; diagnostic preparations and substances for medical purposes; immunotherapies and therapeutic agents in the field of locoregionally active cytokines for medical purposes; immunotherapiestherapeutic agentsdiagnostic preparationsdiagnostic substances in the field of oncology for medical purposes

Class 42

Development in the field of therapeutic biochemicalsimmunoglobulinsantigen-binding fragments and cytokinesengineered cell therapies and immunotherapyoncology and immunocytokines; development of assays for measuringmonitoringtesting and analyzing antibody bindingtherapeutic treatments and patient recoveryfor identifying candidate patient populations for specific therapeutic treatments

Publications

History of USPTO decisions and trademark events.

41 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/13/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/13/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/28/2024

PUBO

PUBLISHED FOR OPPOSITION

05/28/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/08/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/19/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/11/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/11/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/11/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/15/2024

GNRT

NON-FINAL ACTION E-MAILED

03/15/2024

CNRT

NON-FINAL ACTION WRITTEN

03/15/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

03/15/2024

OTHE

CASE RETURNED TO EXAMINATION

03/13/2024

IUCN

NOTICE OF ALLOWANCE CANCELLED

03/13/2024

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

02/21/2024

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

02/21/2024

APET

ASSIGNED TO PETITION STAFF

02/20/2024

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

01/30/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/13/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/13/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/13/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/13/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/14/2023

EX1G

SOU EXTENSION 1 GRANTED

10/12/2023

EXT1

SOU EXTENSION 1 FILED

10/12/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/12/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/25/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/28/2023

PUBO

PUBLISHED FOR OPPOSITION

02/28/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/08/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/23/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/22/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/22/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/22/2022

GNRT

NON-FINAL ACTION E-MAILED

06/22/2022

CNRT

NON-FINAL ACTION WRITTEN

06/22/2022

DOCK

ASSIGNED TO EXAMINER

06/15/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/19/2021

NWAP

NEW APPLICATION ENTERED

09/14/2021

Continuous trademark protection

Get notified about every new filing that threatens LOGIKINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.